Nonrulemaking

Requests that the FDA declare that Triamcinolone Acetonide Cream, 0.25 and 0.05, is suitable for submission as an ANDA.

🏛 Food and Drug Administration (FDA)FDA-2026-P-5989

Pharmaceutical Policy

Documents

7

Total comments

0

all analyzed

Comment status

Closed

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 7 Supporting & Related Material 4 Other 3

Supporting & Related Material· Jun 22, 2026
Amendment to Attachment 3→
Supporting & Related Material· May 27, 2026
Attachment 1→
Supporting & Related Material· May 27, 2026
Attachment 3→